INTRODUCTION
============

Fat grafting has become a widely used method for plastic surgeons and other surgical specialties in recent years \[[@b1-aps-2017-01487]\]. Its application in aesthetic, plastic and reconstructive surgery was recently expanded by translational efforts involving adipose derived progenitor cells and their use in regenerative medicine \[[@b2-aps-2017-01487]\].

There is increasing evidence for fat grafts to play a vital role in novel therapeutic strategies \[[@b3-aps-2017-01487]\]. Most current research is focused on mesenchymal stem cells, while the main clinical applications still consist of fat grafts that resemble adipocyte cluster transplants, without determination or purification of single cell types. For contouring effects, many surgeons prefer the method of Coleman \[[@b1-aps-2017-01487]\] for harvesting and reinjecting.

Still, the fate of these transplanted fat grafts *in vivo* remains quite undefined. The determination of graft localization in a transplantation target is difficult and cannot be simulated *in vitro*. Our objective was to create a novel model for serial fat graft *in vivo* tracing, without the need to harvest the graft for further investigations. Quantum dots (QDs) were evaluated in this model as a labeling agent. QDs are small semiconductor nanocrystals, with a size of usually \<10 nm \[[@b4-aps-2017-01487]\]. QDs have the ability to emit fluorescence when excited with near infrared light. One of the major advantages lies in the wide absorption profile and an up to 10-fold greater molar extinction coefficient compared with organic dyes \[[@b4-aps-2017-01487]\]. We have proven an intracellular uptake of QDs 675 in fat grafts before \[[@b5-aps-2017-01487]\] and evaluated the use of the QDs as a new option for *in vivo* tracking in our current study.

METHODS
=======

Experiments were performed according to the guiding principles for research involving animals and the German legislation on protection of animals. Approval was obtained with the local governmental animal care committee (No. 55.2-1-54-2531-53-08).

BALB/c mice (Janvier, Le Genest Saint Isle, France) were housed at the Department of Pharmaceutical Biology and Biotechnology, Biotechnology and Nanomedicine, Ludwig Maximilians University, Munich. Animals were allowed to accommodate to the standard conditions of the animal facility with free access to mouse chow and water.

Subcutaneous fat was surgically harvested under sterile conditions from inguinal and abdominal region of BALB/c mouse, pooled and mechanically transected with scalpels. Collected fat grafts were diluted in 1 mL NaCl 0.9% on six well plates. There was no collagenase digestion or any other further processing of the harvested fat grafts, which were used immediately for incubation and transplantation experiments. In this setting, determination of vitality was not realizable after harvesting. Fat grafts weight between 0.05 and 0.10 g.

Cadmium-telluride QDs (CdTe-QDs) were synthesized in water according to the previously published method \[[@b6-aps-2017-01487]\]. The negatively charged CdTe-QDs 770 had a diameter of about 6.5 nm and showed a characteristic near infrared excitation profile with a peak at 770 nm with an excitation wavelength of 740 nm \[[@b5-aps-2017-01487]\].

Indocyanine green (Cardiogreen, Sigma-Aldrich, Munich, Germany) was used as a control tracing agent, because its ability to emit a fluorescence tracing signal, that can be compared *in vivo* to QDs in the same experimental setup.

There was no use of cell culture medium or fetal calf serum addition. For incubation experiments and short time storage saline solutions (NaCl 0.9%) were used.

For *in vivo* experiments with fluorescence readings, BALB/c mice could be held under general isoflurane anesthesia with a custom-built small animal anesthesia unit in the IVIS Lumina Imaging System for the recurring scanning procedure (Caliper Life Science, Hopkinton, MA, USA) ([Fig. 1](#f1-aps-2017-01487){ref-type="fig"}). Near infrared excitation was created by the IVIS Lumina Imaging System. Photoluminescence as radiance was measured in photons/s/sr/cm^2^. Signal processing and imaging was performed with the Living Image Software 3.0 (Caliper Life Science). Received fluorescence signals were subtracted by software from the signal of the surrounding area and fused with the corresponding digital photo that was created within the IVIS Lumina Imaging System.

To determine *in vivo* stability of the CdTe-QDs, 0.5 mL of a 9 nmol/L CdTe-QDs solution was injected subcutaneously without a fat graft in a caudocranial direction on the back of the animals under general isoflurane anaesthesia (n=3). Also, indocyanine green (ICG) (0.5 mL of a 4 nmol/L solution) was injected in 0.5 mL aliquots as a control. Photoluminescence was scanned under general anesthesia on day 0, 1, 2, 3, 4, 5, 6, 10, 16, 23, and 30. In addition, feces and urine were collected to document excretion of the labeling substances.

To evaluate a possible correlation of the fluorescence signal with the vitality of the fat grafts, non-vital grafts were used as control group in addition to vital fat grafts for *in vivo* tracking.

To create non-vital grafts as control groups, fat grafts underwent heat-treatment with 80°C for 45 minutes. Afterwards the grafts were cooled down to 37°C and incubation procedures were started. This protocol was necessary, because QDs showed strong adhesion artifacts when confronted with higher temperatures (\>50°C), as well as with other chemicals, like alcoholic derivatives and other chemicals that are frequently used for induction of cell death (data not shown).

For incubation experiments, harvested vital and non-vital fat grafts were incubated with 9 nmol/L CdTe-QDs and rinsed with NaCl 0.9% twice. After the washing procedure, the fat grafts were filled into 2 mL syringes and injected into the back of BALB/c mice under general anesthesia with isoflurane and analgesia with carprofen (n=3). Prior to injection experiments, the target area was shaved to avoid a reduction of photoluminescence. For injection a Strauss cannula, 15 gauge (1.8×43.0 mm) (Dispomed Witt oHG, Gelnhausen, Germany) was used. The puncture site was sealed with 2-octyl cyanoacrylate (Dermabond, Ethicon Inc., Norderstedt, Germany). Every Mouse was scanned serially daily for the first 7days and on day 10, 16, 23, 30, 37, 43, and 50 *in vivo*.

RESULTS
=======

Stability of CdTe-QDs *in vivo*
-------------------------------

To examine physical stability, injected CdTe-QDs (without fat grafts) were followed *in vivo*, as described above. ICG was injected as a control substance.

Photoluminescence results are shown in [Fig. 2](#f2-aps-2017-01487){ref-type="fig"}. The QD 770 luminescence signal was on average reduced to 53.7% after 16 days and showed a steady decline after 4 days. ICG was on average reduced to 41.8% after 24 hours and 16.7% after 3 days. ICG showed a sharp drop until the second day and then was reduced slowly. After 30 days, a remaining luminescence of 22.6%± 16.5% was found for the injected QD 770 and 5.7%±2.4% for the injected ICG.

In the ICG group, fluorescent tracer was found after 24 hours in the feces, documenting the known biliary excretion of ICG (data not shown). There was no measurable fluorescence in the ICG group urine, or in the QD 770 excrements.

Fat graft labeling with QD 770 *in vivo*
----------------------------------------

Vital and non-vital fat grafts were labeled with CdTe-QD 770 and transplanted as described above.

Fluorescence signal follow-up was received from the vital and non-vital fat grafts *in vivo*. After 30 days the signal was deteriorated in the fusion views, but still detectable ([Fig. 3](#f3-aps-2017-01487){ref-type="fig"}).

Absolute fluorescence values ([Fig. 4](#f4-aps-2017-01487){ref-type="fig"}) showed a detectable CdTe-QD 770 signal until the 50th day in the vital fat graft group. In the non-vital group all fat grafts were detected until day 43, whereas one graft was not detected on day 50 anymore. The average luminescence strength of the vital fat grafts was reduced more than 50% after 72 hours. Compared to the non-vital grafts, the initial signal was 5.96 times stronger. When looked at the relative fluorescence values to even out differences in the initial fluorescence levels (luminescence/luminescence on day 0), we found a similar course on the first 5 days and afterwards an almost steady state in the non-vital graft group ([Fig. 5](#f5-aps-2017-01487){ref-type="fig"}).

After 30 days, the remaining fluorescent level was 4.9%±2.5% of the initial fluorescent level in the vital fat grafts and 24.3%± 16.4% in the non-vital fat grafts. The non-vital fat grafts showed comparable absolute levels of photoluminescence as the vital fat grafts ([Fig. 5](#f5-aps-2017-01487){ref-type="fig"}) at this time point. At day 50, the remaining luminescence levels were 4.2%±1.7% for the vital grafts and 6.3%± 5.6% with one graft not being detectable anymore from the non-vital fat grafts.

After 50 days, the tracing was terminated. Adipocyte clusters were surgically excised and openly examined under the IVIS Lumina System ([Fig. 6](#f6-aps-2017-01487){ref-type="fig"}).

As an incidental observation, transplanted vital fat grafts showed an increased revascularization at the end of the study ([Fig. 6A](#f6-aps-2017-01487){ref-type="fig"}), if compared to transplanted non-vital fat grafts. Fat grafts showed a remaining fluorescence signal *ex vivo* after 50 days ([Fig. 6B](#f6-aps-2017-01487){ref-type="fig"}).

DISCUSSION
==========

Fat cluster grafting has become a standard plastic surgical procedure \[[@b1-aps-2017-01487],[@b7-aps-2017-01487]\]. Unfortunately, there is not much experimental data supporting the clinical success of the frequently employed method \[[@b8-aps-2017-01487]\]. Partly, the lacking data is caused by a scientific focus, which is currently put mainly on progenitor or stem cells, promising a broad functionality \[[@b9-aps-2017-01487]\].

There have been few models for the follow-up of fat derived grafts using fluorescent dye. Rieck and Schlaak \[[@b10-aps-2017-01487]\] used PKH26, a lipophilic dye for staining a collagenized fat derived cell suspension, which was injected subcutaneous, intramuscularly and subcapsular into the kidney and was able to demonstrate a fluorescent signal even after 6 months. The actual measurement was done ex vivo in histological preparations under confocal microscopy. Also, Rieck and Schlaak \[[@b11-aps-2017-01487]\] published a Lewis rat model for tracking of preadipocytes with PKH26 and demonstrated the examination ex vivo under confocal microscopy. Further substances for tracking of human preadipocytes were tested *in vitro* from Hemmrich et al. \[[@b12-aps-2017-01487]\], stating a high toxicity for carboxyfluorescein succinimidyl ester (CFSE) and CM-DiI. CFSE, CM-DiI, and PKH 26 showed a remaining fluorescence of around 4% to 6% after 35 days *in vitro*. Zhou et al. \[[@b13-aps-2017-01487]\] used luciferase transgenic rats and bioimaging to examine the difference between transplanted fat tissue with and without a stromal vascular fraction, showing a higher survival rate for the stromal vascular fraction group at 63 days. Furthermore Bliley et al. \[[@b14-aps-2017-01487]\] used dioctadecyl-tetramethylindotricarbocyanine iodide, a near-infrared dye to track the stromal vascular fraction of fat grafts *in vivo*.

Our animal model clearly was inspired by the clinical use of micro fat grafts \[[@b15-aps-2017-01487]\]. Since our model uses fat grafts in the form of micro fat cluster, there is a limitation of the scientific acuity concerning the determination of vitality, as well as cell count and origin. But on the other hand, fat alterations like collagenase digestion would have altered membrane proteins and cell viability. We were willing to take this drawback in return for an animal model that reflects the clinical reality.

QDs were introduced as nanocrystals with unique luminescent properties and stable fluorescence emission \[[@b4-aps-2017-01487],[@b16-aps-2017-01487]\]. There has been a tremendous increase in the use of semiconductor QDs as a fluorescent label for imaging, tracing and sensing in living tissues \[[@b5-aps-2017-01487],[@b17-aps-2017-01487],[@b18-aps-2017-01487]\]. There have been attempts to couple QDs to specific ligands for target specificity \[[@b17-aps-2017-01487]-[@b19-aps-2017-01487]\]. For our experiments, we used custom-built CdTe-QDs that were negatively charged and had a diameter of 7 nm.

Yukawa et al. \[[@b20-aps-2017-01487]\] described the use of CdSe/ZnS-core/shell nanocrystals as a potential labeling tool for adipose tissue-derived stem cells (ASCs). Also, a transfection with QDs of ASCs with a cell penetrating peptide was reported. The fluorescence intensity was maintained for at least 2 weeks with the used QDs 655 \[[@b21-aps-2017-01487]\].

To our knowledge, our experiment presented for the first time the tracking of fat grafts in a continuous *in vivo* model. The chosen marker QD 770 showed the potential for a useful applicability.

The non-vital fat grafts, which were chosen as controls, showed a reduced absolute QDs uptake in our experiments, but we were not able to correlate a specific uptake to the viability of a fat graft. Therefore, the QDs labeling tool remains a tracking, rather than a viability tool, which is a limitation of the current experimental model. *In vivo* online tracking might play a role for follow-up of functional fat grafts for nerve cushioning, wound healing or other new indications, especially in an experimental setup. Other methods should be applied, if vitality of fat grafts is subject of an investigation.

Morphologically the fluorescent shape of the injected clusters became cohesive over time, although the fat transplantation was performed in a pearl array. This was already observed in other fat graft experiments and was earlier contributed to the movement of the animals \[[@b22-aps-2017-01487]\]. Also, this mechanism seems to be a potential contributor for an intercalated increase of fluorescence values per area in some groups over time.

The signals also showed no hint for *in vivo* leaking to the surrounding of the labeling markers in the QD in the form of radial spreading, although leaking poses a potential problem that has to stay in the focus of further research.

QD 770 showed a sustaining labeling quality in form of a slow fading out of photoluminescence.

After 16 days *in vivo* tracing, there was on average 14.1% of the initial QDs fluorescence level. Therefore, QDs seem to permit tracing for medium to long-term tracking experiments.

Toxicity of QDs is to date not finally evaluated. Since the core of QDs are usually based on heavy metals, like cadmium in the used CdTe-QDs, toxicity has to be addressed in further studies \[[@b4-aps-2017-01487]\]. We did not observe acute toxicity on microscopic evaluation. CdTe-QDs reportedly showed cytotoxic properties to a breast cancer cell line, which were not dose dependent to the intracellular Cd2+levels \[[@b23-aps-2017-01487]\]. Other groups observed no histological changes with CdSe(0.25)Te(0.75)/CdS -QDs in major organs, when administered in a mouse model, even at high doses \[[@b24-aps-2017-01487]\]. The accumulation of nanoparticles in organs, like liver or spleen was recently described \[[@b25-aps-2017-01487]\].

*In vivo* tracking of fat graft with QDs represents a new tool in the arsenal of applied nanotechnology, while further tests are necessary to exclude a potential toxicity. The application of this novel model for fat graft tracing could be useful in the evaluation of new functional and aesthetical fat graft transplants.
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![Experimental setup for online detection\
IVIS Lumina Imaging System with custombuilt animal anesthesia unit for online fluorescence readings in living small animals under general anesthesia.](aps-2017-01487f1){#f1-aps-2017-01487}

![Course of QDs injection without fat graft\
Photoluminescence time course of dorsally injected cadmium-telluride quantum dots (CdTe-QDs) 770 and indocyanine green (ICG) as control in mice. Data are normalized to the initial fluorescent values and represent (mean±SD, n=3).](aps-2017-01487f2){#f2-aps-2017-01487}

![*In vivo* detection of transplanted fat clusters\
*In vivo* fluorescence tracing of transplanted fat clusters with cadmium-telluride quantum dots (CdTe-QDs) 770. The fluorescence reading was fused online with a picture of the target area.](aps-2017-01487f3){#f3-aps-2017-01487}

![Photoluminescence of vital and non-vital grafts\
Absolute fluorescence values (mean±SD, n=3) of quantum dots (QDs) 770 incubated and subcutaneous transplanted fat clusters. The control group consisted of non-vital fat grafts (NV-FG) (n=3).](aps-2017-01487f4){#f4-aps-2017-01487}

![Normalized photoluminescence of transplanted fat grafts\
Relative photoluminescence of quantum dots (QDs) 770 (mean±SD, n=3) incubated and subcutaneous transplanted fat clusters, compared to the initial value. NV-FG, non-vital fat grafts.](aps-2017-01487f5){#f5-aps-2017-01487}

![Examination of fat graft\
Fat cluster transplants were excised and examined 50 days after cluster labeling with cadmium-telluride quantum dots (CdTe-QD) 770: vital transplanted adipocyte clusters showed frequently increased revascularization (A). The graft result presents spherical, despite of a more areal transplantion of the fat graft, probably based on a pooling effect due to animal movement. There was a remaining direct fluorescence signal on the transplants, when examined *ex vivo* (B). Not all transplanted fat clusters showed an *in vivo* signal after 50 days.](aps-2017-01487f6){#f6-aps-2017-01487}

[^1]: Parts of this work were presented at the DGPRAEC (German Society of Plastic, Reconstructive and Aesthetic Surgeons) meeting on September 18, 2010, in Dresden, Germany.
